ExploRNA Therapeutics was proud to take part in the 10th Central European Congress of Life Sciences (EUROBIOTECH 2026) in Kraków, Poland. As a hub for regional and global life science breakthroughs, the congress provided an ideal stage to showcase our latest advancements in mRNA technology.

Our scientific leadership contributed key insights to the scientific program across two feature sessions:

  • Improving mRNA Technology: CEO Prof. Jacek Jemielity delivered talk S1L28, “How can mRNA technology be improved for therapeutic applications?”, addressing key innovations to boost expression, stability, and therapeutic efficacy.

  • Targeted Therapeutic Applications: mRNA Team Leader Mirosław Śmietański, PhD, presented poster P1.28, “mRNA-based DNase 1 therapy for neutrophil extracellular traps (NETs) degradation”, highlighting a promising approach to treating inflammatory conditions.

We thank the organisers and all who connected with our team in Kraków as we continue working to unlock the full potential of mRNA-based therapeutics.